For more than 30 years now, Mayne Pharma has developed high-quality generic products to offer patients improved access and affordable options to medications that enhance their lives.
Our robust portfolio of generic products highlights Mayne Pharma’s known expertise for advanced, complex and niche pharmaceuticals.
Generic prescription drugs saved American consumers $227 billion in 2015 and now represent nearly 90 percent of all prescriptions filled in the United States annually, according to the Association for Accessible Medicines.
Mayne Pharma is proud to apply its successful track record of pharmaceutical innovation to developing new generic drugs that offer patients greater access to more affordable medications. To learn more about generic pharmaceuticals and how they both increase access and decrease health-care costs, visit www.accessiblemeds.org.
Our catalog addresses a broad range of therapeutic treatment areas and continues to grow in size and scope. We invite you to browse our offerings to learn more.
For our Controlled Substance Ordering System, please visit our CSOS portal.